{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:44:02Z","timestamp":1765039442151},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13104-018-3634-9","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T05:15:35Z","timestamp":1533186935000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Body iron status of children and adolescents with transfusion dependent \u03b2-thalassaemia: trends of serum ferritin and associations of optimal body iron control"],"prefix":"10.1186","volume":"11","author":[{"given":"Tharindi","family":"Suriapperuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindu","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chamila","family":"Mettananda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja","family":"Premawardhena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachith","family":"Mettananda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"issue":"9813","key":"3634_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0140-6736(11)60283-3","volume":"379","author":"DR Higgs","year":"2012","unstructured":"Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassaemia. Lancet. 2012;379(9813):373\u201383.","journal-title":"Lancet"},{"issue":"6","key":"3634_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1365-2141.2011.08742.x","volume":"154","author":"DJ Weatherall","year":"2011","unstructured":"Weatherall DJ. The challenge of haemoglobinopathies in resource-poor countries. Br J Haematol. 2011;154(6):736\u201344.","journal-title":"Br J Haematol"},{"issue":"9206","key":"3634_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(99)08246-X","volume":"355","author":"S Silva de","year":"2000","unstructured":"de Silva S, Fisher CA, Premawardhena A, Lamabadusuriya SP, Peto TE, Perera G, Old JM, Clegg JB, Olivieri NF, Weatherall DJ. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group. Lancet. 2000;355(9206):786\u201391.","journal-title":"Lancet"},{"issue":"2","key":"3634_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4038\/cmj.v62i2.8469","volume":"62","author":"S Mettananda","year":"2017","unstructured":"Mettananda S, de Silva DG. Anaemia in children: are we using the correct prevention strategies? Ceylon Med J. 2017;62(2):73\u20136.","journal-title":"Ceylon Med J"},{"issue":"2","key":"3634_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.hoc.2017.11.003","volume":"32","author":"S Mettananda","year":"2018","unstructured":"Mettananda S, Higgs DR. Molecular basis and genetic modifiers of thalassemia. Hematol Oncol Clin North Am. 2018;32(2):177\u201391.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"13","key":"3634_CR6","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/blood-2010-08-300335","volume":"118","author":"EA Rachmilewitz","year":"2011","unstructured":"Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011;118(13):3479\u201388.","journal-title":"Blood"},{"issue":"24","key":"3634_CR7","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1182\/blood-2015-03-633594","volume":"125","author":"S Mettananda","year":"2015","unstructured":"Mettananda S, Gibbons RJ, Higgs DR. Alpha-globin as a molecular target in the treatment of beta-thalassemia. Blood. 2015;125(24):3694\u2013701.","journal-title":"Blood"},{"issue":"1","key":"3634_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/nyas.12988","volume":"1368","author":"S Mettananda","year":"2016","unstructured":"Mettananda S, Gibbons RJ, Higgs DR. Understanding alpha-globin gene regulation and implications for the treatment of beta-thalassemia. Ann N Y Acad Sci. 2016;1368(1):16\u201324.","journal-title":"Ann N Y Acad Sci"},{"key":"3634_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/9780470696705","volume-title":"The thalassaemia syndromes","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ, Clegg JB. The thalassaemia syndromes. 4th ed. Oxford: Blackwell Science; 2001.","edition":"4"},{"issue":"3","key":"3634_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4038\/sljch.v46i3.8318","volume":"46","author":"S Mettananda","year":"2017","unstructured":"Mettananda S. Thalassaemia: in a quest towards an ultimate cure. Sri Lanka J Child Health. 2017;46(3):203\u201310.","journal-title":"Sri Lanka J Child Health"},{"issue":"1","key":"3634_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/nyas.13088","volume":"1368","author":"JL Kwiatkowski","year":"2016","unstructured":"Kwiatkowski JL. Current recommendations for chelation for transfusion-dependent thalassemia. Ann N Y Acad Sci. 2016;1368(1):107\u201314.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"3634_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.hoc.2017.11.012","volume":"32","author":"JL Fernandes","year":"2018","unstructured":"Fernandes JL. MRI for iron overload in thalassemia. Hematol Oncol Clin North Am. 2018;32(2):277\u201395.","journal-title":"Hematol Oncol Clin North Am"},{"key":"3634_CR13","volume-title":"Guidelines for the management of transfusion dependent thalassaemia (TDT)","author":"MD Cappellini","year":"2014","unstructured":"Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V. Guidelines for the management of transfusion dependent thalassaemia (TDT). 3rd ed. Cyprus: Thalassaemia International Federation; 2014.","edition":"3"},{"issue":"2","key":"3634_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.hoc.2017.11.010","volume":"32","author":"JB Porter","year":"2018","unstructured":"Porter JB, Garbowski MW. Interaction of transfusion and iron chelation in thalassemias. Hematol Oncol Clin North Am. 2018;32(2):247\u201359.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"3634_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4038\/sljch.v47i2.8484","volume":"47","author":"S Mettananda","year":"2018","unstructured":"Mettananda S. Management of thalassaemia. Sri Lanka J Child Health. 2018;47(2):159\u201365.","journal-title":"Sri Lanka J Child Health"},{"key":"3634_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5348\/ijbti-2017-32-OA-5","volume":"7","author":"AMDS Karunaratna","year":"2017","unstructured":"Karunaratna AMDS, Ranasingha JGS, Mudiyanse RM. Iron overload in beta thalassemia major patients. Int J Blood Transfus Immunohematol. 2017;7:33\u201340.","journal-title":"Int J Blood Transfus Immunohematol"},{"issue":"4","key":"3634_CR17","first-page":"328","volume":"8","author":"AK Mishra","year":"2013","unstructured":"Mishra AK, Tiwari A. Iron overload in beta thalassaemia major and intermedia patients. Maedica. 2013;8(4):328\u201332.","journal-title":"Maedica"},{"key":"3634_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/1756-0500-4-287","volume":"4","author":"H Riaz","year":"2011","unstructured":"Riaz H, Riaz T, Khan MU, Aziz S, Ullah F, Rehman A, Zafar Q, Kazi AN. Serum ferritin levels, socio-demographic factors and desferrioxamine therapy in multi-transfused thalassemia major patients at a government tertiary care hospital of Karachi, Pakistan. BMC Res Notes. 2011;4:287.","journal-title":"BMC Res Notes"},{"key":"3634_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4038\/sljch.v40i2.3090","volume":"40","author":"PS Samarakoon","year":"2011","unstructured":"Samarakoon PS, Wijesuriya AP. A clinical audit of thalassaemia management at the Lady Ridgeway Hospital for Children, Colombo. Sri Lanka J Child Health. 2011;40:48\u201353.","journal-title":"Sri Lanka J Child Health"},{"issue":"10116","key":"3634_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","volume":"391","author":"AT Taher","year":"2018","unstructured":"Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155\u201367.","journal-title":"Lancet"},{"issue":"1","key":"3634_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41467-017-00479-7","volume":"8","author":"S Mettananda","year":"2017","unstructured":"Mettananda S, Fisher CA, Hay D, Badat M, Quek L, Clark K, Hublitz P, Downes D, Kerry J, Gosden M, et al. Editing an alpha-globin enhancer in primary human hematopoietic stem cells as a treatment for beta-thalassemia. Nat Commun. 2017;8(1):424.","journal-title":"Nat Commun"},{"issue":"3","key":"3634_CR22","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.3324\/haematol.2016.155655","volume":"102","author":"S Mettananda","year":"2017","unstructured":"Mettananda S, Fisher CA, Sloane-Stanley JA, Taylor S, Oppermann U, Gibbons RJ, Higgs DR. Selective silencing of alpha-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of beta-thalassemia. Haematologica. 2017;102(3):e80\u20134.","journal-title":"Haematologica"},{"issue":"16","key":"3634_CR23","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1056\/NEJMe1802169","volume":"378","author":"A Biffi","year":"2018","unstructured":"Biffi A. Gene Therapy as a Curative Option for beta-Thalassemia. N Engl J Med. 2018;378(16):1551\u20132.","journal-title":"N Engl J Med"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3634-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-018-3634-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3634-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T19:18:20Z","timestamp":1564687100000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-018-3634-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3634"],"URL":"https:\/\/doi.org\/10.1186\/s13104-018-3634-9","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]},"assertion":[{"value":"28 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"547"}}